Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy
Articolo
Data di Pubblicazione:
1995
Citazione:
Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy / G. Gasparini, M. Barbareschi, P. Boracchi, P. Verderio, O. Caffo, S. Meli, P. Dalla Palma, E. Marubini, P. Bevilacqua. - In: CANCER JOURNAL FROM SCIENTIFIC AMERICAN. - ISSN 1081-4442. - 1:2(1995), pp. 131-41-141.
Abstract:
Experimental studies suggest that angiogenesis is necessary for breast cancer progression and metastasis and that it may play a role in responsiveness to some chemotherapeutic agents and to tamoxifen. To investigate whether angiogenesis predicts the clinical outcome of patients with node-positive breast cancer, we determined intratumoral microvessel density in a series of patients treated with either adjuvant hormone therapy (n=84) or chemotherapy (n= 107).
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Antineoplastic Agents, Hormonal; Lymphatic Metastasis; Humans; Prognosis; Aged; Breast Neoplasms; Tamoxifen; Carcinoma, Lobular; Survival Rate; Cisplatin; Fluorouracil; Adult; Treatment Outcome; Antineoplastic Combined Chemotherapy Protocols; Methotrexate; Middle Aged; Carcinoma, Ductal, Breast; Neovascularization, Pathologic; Lymph Nodes; Chemotherapy, Adjuvant; Female
Elenco autori:
G. Gasparini, M. Barbareschi, P. Boracchi, P. Verderio, O. Caffo, S. Meli, P. Dalla Palma, E. Marubini, P. Bevilacqua
Link alla scheda completa: